127 related articles for article (PubMed ID: 33987767)
1. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
[TBL] [Abstract][Full Text] [Related]
2. Metastasis Prevalence and Survival of Patients with T1-2 Gastric Neuroendocrine Tumor Treated with Endoscopic Therapy and Surgery.
Wang M; Cheng S; Zhu L; Xu T; Zhang J; Zhang Y; Ping J; Wang R
Dig Dis Sci; 2022 Jul; 67(7):3228-3238. PubMed ID: 34272627
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
4. Comparable long-term survival of patients with colorectal or gastric gastrointestinal stromal tumors treated with endoscopic vs. surgical resection.
Yin L; Wang J; Zhao R; Chen K; Ji Z; Ji G; Zhang X
Surg Endosc; 2022 Jun; 36(6):4215-4225. PubMed ID: 34622298
[TBL] [Abstract][Full Text] [Related]
5. Effects of endoscopic therapy and surgical resection on long-term survival outcomes in patients with duodenal gastrointestinal stromal tumors: a surveillance, epidemiology, and end result program analysis.
Yan H; Liu X; Yin L; Han H; Jin Y; Zhu X; Liu Z
Surg Endosc; 2022 Nov; 36(11):8030-8038. PubMed ID: 35437643
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
7. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
Chen Q; Chen J; Huang Z; Zhao H; Cai J
Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
[TBL] [Abstract][Full Text] [Related]
8. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
[TBL] [Abstract][Full Text] [Related]
9. Comparing surgical and endoscopic resection approaches for colorectal neuroendocrine tumors within the diameter range of 10-20mm: an inverse probability weighting analysis based on the SEER database.
Xu J; Liang R; Cai Q; Liu Y; Ge X; Lai B; Mao S; Cao J; Wang J
Front Endocrinol (Lausanne); 2024; 15():1378968. PubMed ID: 38601205
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Primary Tumor Resection for Metastatic Small Intestine Neuroendocrine Tumors and Survival: A Propensity Score-Matched Analysis.
Yan H; Yin L; Han H; Jin Y; Liu Z
J Invest Surg; 2022 Jun; 35(6):1239-1247. PubMed ID: 34991432
[TBL] [Abstract][Full Text] [Related]
11. Second primary cancers and survival among neuroendocrine tumor patients.
Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
[TBL] [Abstract][Full Text] [Related]
12. Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors.
Wu X; Peng C; Lin M; Li Z; Yang X; Liu J; Yang X; Zuo X
J Endocrinol Invest; 2024 Mar; 47(3):671-681. PubMed ID: 37653287
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: A propensity-matched study based on the SEER database.
Wen J; Chen J; Chen D; Liu D; Xu X; Huang L; Cao J; Zhang J; Gu Y; Fan M; Chen Y
Thorac Cancer; 2018 Dec; 9(12):1603-1613. PubMed ID: 30276969
[TBL] [Abstract][Full Text] [Related]
15. Primary neuroendocrine tumors of the ovary: Management and outcomes.
Pang L; Guo Z
Cancer Med; 2021 Dec; 10(23):8558-8569. PubMed ID: 34773393
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
Chai Y; Lin B; Zhong J; Wu X; Lin X; Ge X; Jiang J; Liang Z; Liu S; Gu C
Eur J Surg Oncol; 2024 Mar; 50(6):108262. PubMed ID: 38531231
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic and surgical treatment of malignant colorectal polyps: a population-based comparative study.
Mounzer R; Das A; Yen RD; Rastogi A; Bansal A; Hosford L; Wani S
Gastrointest Endosc; 2015 Mar; 81(3):733-740.e2. PubMed ID: 25708762
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching.
Shen F; Hong X
Int J Colorectal Dis; 2019 Aug; 34(8):1375-1383. PubMed ID: 31201493
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2.
Shen F; Cui J; Hong X; Yu F; Bao X
Int J Colorectal Dis; 2019 Jun; 34(6):1095-1104. PubMed ID: 31016378
[TBL] [Abstract][Full Text] [Related]
20. The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis.
Cao L; Wu HF; Zhao L; Bai Y; Jiang ZL; Yang WJ; Liu SX
J Radiat Res; 2020 Jul; 61(4):594-601. PubMed ID: 32567658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
